• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国中间高血糖人群 2 型糖尿病发病风险预测模型的系统评价和外部验证研究。

Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.

机构信息

Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, Laboratory of Diabetes and Islet Transplantation Research, West China Medical School, West China Hospital, Sichuan University, Guo Xue Lane 37, Chengdu, China.

Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Cardiovasc Diabetol. 2022 Sep 13;21(1):182. doi: 10.1186/s12933-022-01622-5.

DOI:10.1186/s12933-022-01622-5
PMID:36100925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9472437/
Abstract

BACKGROUND

People with intermediate hyperglycemia (IH), including impaired fasting glucose and/or impaired glucose tolerance, are at higher risk of developing type 2 diabetes (T2D) than those with normoglycemia. We aimed to evaluate the performance of published T2D risk prediction models in Chinese people with IH to inform them about the choice of primary diabetes prevention measures.

METHODS

A systematic literature search was conducted to identify Asian-derived T2D risk prediction models, which were eligible if they were built on a prospective cohort of Asian adults without diabetes at baseline and utilized routinely-available variables to predict future risk of T2D. These Asian-derived and five prespecified non-Asian derived T2D risk prediction models were divided into BASIC (clinical variables only) and EXTENDED (plus laboratory variables) versions, with validation performed on them in three prospective Chinese IH cohorts: ACE (n = 3241), Luzhou (n = 1333), and TCLSIH (n = 1702). Model performance was assessed in terms of discrimination (C-statistic) and calibration (Hosmer-Lemeshow test).

RESULTS

Forty-four Asian and five non-Asian studies comprising 21 BASIC and 46 EXTENDED T2D risk prediction models for validation were identified. The majority were at high (n = 43, 87.8%) or unclear (n = 3, 6.1%) risk of bias, while only three studies (6.1%) were scored at low risk of bias. BASIC models showed poor-to-moderate discrimination with C-statistics 0.52-0.60, 0.50-0.59, and 0.50-0.64 in the ACE, Luzhou, and TCLSIH cohorts respectively. EXTENDED models showed poor-to-acceptable discrimination with C-statistics 0.54-0.73, 0.52-0.67, and 0.59-0.78 respectively. Fifteen BASIC and 40 EXTENDED models showed poor calibration (P < 0.05), overpredicting or underestimating the observed diabetes risk. Most recalibrated models showed improved calibration but modestly-to-severely overestimated diabetes risk in the three cohorts. The NAVIGATOR model showed the best discrimination in the three cohorts but had poor calibration (P < 0.05).

CONCLUSIONS

In Chinese people with IH, previously published BASIC models to predict T2D did not exhibit good discrimination or calibration. Several EXTENDED models performed better, but a robust Chinese T2D risk prediction tool in people with IH remains a major unmet need.

摘要

背景

与血糖正常者相比,具有中间高血糖(IH)的人群,包括空腹血糖受损和/或葡萄糖耐量受损,发生 2 型糖尿病(T2D)的风险更高。我们旨在评估已发表的 T2D 风险预测模型在中国 IH 人群中的表现,为他们提供选择初级糖尿病预防措施的信息。

方法

系统地检索了亚洲人群中 T2D 风险预测模型的文献,这些模型符合以下条件:在没有糖尿病的亚洲成年人前瞻性队列中建立,使用常规可获得的变量来预测 T2D 的未来风险。这些亚洲衍生模型和五个预先指定的非亚洲衍生 T2D 风险预测模型分为 BASIC(仅临床变量)和 EXTENDED(加实验室变量)版本,并在中国三个前瞻性 IH 队列(ACE[3241 例]、泸州[1333 例]和 TCLSIH[1702 例])中对其进行验证。使用 C 统计量(discrimination)和 Hosmer-Lemeshow 检验(calibration)评估模型性能。

结果

共确定了 44 项亚洲和 5 项非亚洲研究,包括 21 项 BASIC 和 46 项 EXTENDED T2D 风险预测模型用于验证。其中大多数为高(n=43,87.8%)或不明确(n=3,6.1%)偏倚风险,只有 3 项研究(6.1%)为低偏倚风险。BASIC 模型的区分度较差,在 ACE、泸州和 TCLSIH 队列中的 C 统计量分别为 0.52-0.60、0.50-0.59 和 0.50-0.64。EXTENDED 模型的区分度较差至可接受,C 统计量分别为 0.54-0.73、0.52-0.67 和 0.59-0.78。15 项 BASIC 和 40 项 EXTENDED 模型的校准较差(P<0.05),预测的观察到的糖尿病风险过高或过低。在三个队列中,大多数重新校准的模型显示出更好的校准,但仍有适度至严重高估糖尿病风险。NAVIGATOR 模型在三个队列中的区分度最好,但校准较差(P<0.05)。

结论

在中国 IH 人群中,先前发表的用于预测 T2D 的 BASIC 模型并未表现出良好的区分度或校准度。一些 EXTENDED 模型表现更好,但在中国 IH 人群中仍需要一种可靠的 T2D 风险预测工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/388b6f941efa/12933_2022_1622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/07bdd16c3d1c/12933_2022_1622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/d42728ef9ce6/12933_2022_1622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/388b6f941efa/12933_2022_1622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/07bdd16c3d1c/12933_2022_1622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/d42728ef9ce6/12933_2022_1622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e1/9472437/388b6f941efa/12933_2022_1622_Fig3_HTML.jpg

相似文献

1
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.中国中间高血糖人群 2 型糖尿病发病风险预测模型的系统评价和外部验证研究。
Cardiovasc Diabetol. 2022 Sep 13;21(1):182. doi: 10.1186/s12933-022-01622-5.
2
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.预测患有冠心病和糖耐量受损的中国人患2型糖尿病的风险。
J Diabetes. 2021 Oct;13(10):817-826. doi: 10.1111/1753-0407.13175. Epub 2021 Mar 17.
3
Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.预测 2 型糖尿病发病风险的模型:系统文献检索和独立外部验证研究。
BMJ. 2012 Sep 18;345:e5900. doi: 10.1136/bmj.e5900.
4
Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.中国南京人群 2 型糖尿病患者五年心血管疾病风险预测:来自中国南京的推导和英国苏格兰的外部验证。
Glob Heart. 2022 Jul 28;17(1):46. doi: 10.5334/gh.1131. eCollection 2022.
5
External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.对 KORA S4/F4 预测模型在老年人群中发生 2 型糖尿病风险的外部验证:PREVEND 研究。
Eur J Epidemiol. 2012 Jan;27(1):47-52. doi: 10.1007/s10654-011-9648-4. Epub 2012 Jan 4.
6
Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.2 型糖尿病患者肾病预测模型的性能:系统评价和外部验证研究。
BMJ. 2021 Sep 28;374:n2134. doi: 10.1136/bmj.n2134.
7
Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.开发和验证 CHIME 模拟模型,以评估中国人群中糖尿病前期和 2 型糖尿病的终生健康结局:一项建模研究。
PLoS Med. 2021 Jun 24;18(6):e1003692. doi: 10.1371/journal.pmed.1003692. eCollection 2021 Jun.
8
External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.工具预测心血管疾病、2 型糖尿病或慢性肾脏病 7 年发病风险的外部验证。
J Gen Intern Med. 2018 Feb;33(2):182-188. doi: 10.1007/s11606-017-4231-7. Epub 2017 Dec 4.
9
External validation of prognostic models for chronic kidney disease among type 2 diabetes.2 型糖尿病慢性肾脏病预后模型的外部验证。
J Nephrol. 2022 Jul;35(6):1637-1653. doi: 10.1007/s40620-021-01220-w. Epub 2022 Jan 8.
10
Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.非糖尿病人群高血糖患者 2 型糖尿病风险预测:利用英国初级医疗数据进行模型推导和验证。
BMJ Open. 2020 Oct 23;10(10):e037937. doi: 10.1136/bmjopen-2020-037937.

引用本文的文献

1
Pathway insights and predictive modeling for type 2 diabetes using polygenic risk scores.使用多基因风险评分对2型糖尿病进行通路洞察和预测建模。
Sci Rep. 2025 Aug 7;15(1):28956. doi: 10.1038/s41598-025-13391-8.
2
Approaches to predict future type 2 diabetes mellitus and chronic kidney disease: A scoping review.预测未来2型糖尿病和慢性肾脏病的方法:一项范围综述
PLoS One. 2025 Jun 11;20(6):e0325182. doi: 10.1371/journal.pone.0325182. eCollection 2025.
3
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.

本文引用的文献

1
New risk score model for identifying individuals at risk for diabetes in southwest China.用于识别中国西南部糖尿病高危个体的新型风险评分模型。
Prev Med Rep. 2021 Oct 24;24:101618. doi: 10.1016/j.pmedr.2021.101618. eCollection 2021 Dec.
2
Machine Learning for Predicting the 3-Year Risk of Incident Diabetes in Chinese Adults.用于预测中国成年人新发糖尿病3年风险的机器学习
Front Public Health. 2021 Jun 29;9:626331. doi: 10.3389/fpubh.2021.626331. eCollection 2021.
3
Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
多人群蛋白质组学分析提高了 2 型糖尿病风险预测能力并发现了新的药物靶点。
Diabetes Care. 2024 Jun 1;47(6):1012-1019. doi: 10.2337/dc23-2145.
4
CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients.CT 衍生的血流储备分数用于预测糖尿病患者的主要不良心血管事件。
Cardiovasc Diabetol. 2023 Mar 21;22(1):65. doi: 10.1186/s12933-023-01801-y.
使用简化形式对预测模型偏倚评估工具(PROBAST)进行大规模验证:高偏倚风险模型显示出较差的区分度。
J Clin Epidemiol. 2021 Oct;138:32-39. doi: 10.1016/j.jclinepi.2021.06.017. Epub 2021 Jun 24.
4
Nomogram Predicting the Risk of Progression from Prediabetes to Diabetes After a 3-Year Follow-Up in Chinese Adults.预测中国成年人3年随访后糖尿病前期进展为糖尿病风险的列线图
Diabetes Metab Syndr Obes. 2021 Jun 14;14:2641-2649. doi: 10.2147/DMSO.S307456. eCollection 2021.
5
A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.基于非侵入性指标预测非酒精性脂肪性肝病患者 8 年内 2 型糖尿病发病风险的预测模型:一项基于人群的回顾性队列研究。
Biomed Res Int. 2021 May 14;2021:5527460. doi: 10.1155/2021/5527460. eCollection 2021.
6
Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study.非肥胖成年人2型糖尿病5年发病预测模型的推导与验证:一项基于人群的队列研究
Diabetes Metab Syndr Obes. 2021 May 11;14:2087-2101. doi: 10.2147/DMSO.S304994. eCollection 2021.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.预测患有冠心病和糖耐量受损的中国人患2型糖尿病的风险。
J Diabetes. 2021 Oct;13(10):817-826. doi: 10.1111/1753-0407.13175. Epub 2021 Mar 17.
9
Development and Validation of a Nomogram to Predict Type 2 Diabetes Mellitus in Overweight and Obese Adults: A Prospective Cohort Study from 82938 Adults in China.预测超重和肥胖成年人2型糖尿病的列线图的开发与验证:一项来自中国82938名成年人的前瞻性队列研究
Int J Endocrinol. 2020 Dec 7;2020:8899556. doi: 10.1155/2020/8899556. eCollection 2020.
10
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.基于病理生理学的 2 型糖尿病高危个体亚表型分型。
Nat Med. 2021 Jan;27(1):49-57. doi: 10.1038/s41591-020-1116-9. Epub 2021 Jan 4.